Clinical trials
Phase 3 Bipolar Disorder trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sumitomo Pharma America, Inc. | 5 |
| AstraZeneca | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Bristol-Myers Squibb | 1 |
| Forest Laboratories | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bipolar Disorder | 13 |
| Mania | 2 |
| Autistic Disorder | 1 |
| Schizophrenia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.